Cover Image
市場調查報告書

全球新生兒篩檢市場:產業分析與市場預測

Global Newborn Screening Market - Industry Analysis and Market Forecast (2016 - 2021)

出版商 Mordor Intelligence LLP 商品編碼 319330
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球新生兒篩檢市場:產業分析與市場預測 Global Newborn Screening Market - Industry Analysis and Market Forecast (2016 - 2021)
出版日期: 2016年08月01日 內容資訊: 英文 193 Pages
簡介

代謝性疾病和遺傳性疾病以各種形式妨礙嬰兒正常的身體,精神發展。現在透過簡單的血液檢驗,可判定是否最後成為問題的症狀。 早期診斷恰當治療,為未來發展帶來大幅差異。

本報告提供全球新生兒篩檢市場相關調查、篩檢的一般疾病、檢驗的種類、技術概要等彙整資料。

第1章 概要

第2章 篩檢的最常見疾病

  • PKU
  • 先天性甲狀腺機能低下症
  • 半乳糖血症
  • 鐮形血球貧血症
  • 生物素酵素缺損
  • 先天性腎上腺增生症
  • 械槭糖漿尿症
  • 酪胺酸血症
  • 囊狀纖維化症
  • MCAD缺損
  • 弓蟲症
  • 聽覺篩檢

第3章 新生兒篩檢市場類別

  • 檢驗的種類
    • 血液檢驗
    • 聽力診斷
    • 先天性心臟病檢驗
    • 脈搏血氧飽和度

第4章 新生兒篩檢市場:各技術

  • 串聯式質譜分析
  • 血色素電泳檢驗
  • 免疫檢測及酵素化驗
  • 聽覺篩檢
  • 脈衝脈搏血氧飽和度篩檢

第5章 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global newborn screening market is expected to reach USD XX million by 2021, growing at a CAGR of XX%. Newborn screening is performed to screen infants after birth for the detection of any health conditions or diseases that can be fatal but are not detected during birth. The newborn screening tests are basically an evaluation of metabolites and blood samples. These tests vary according to different country jurisdictions. In many areas, newborn screening tests include screening for hearing loss and congenital heart disease. The major diseases screened for are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea and congenital heart disease.

Global Newborn Screening Market- Market Dynamics

The report details several driving and restraining factors for the global newborn screening market. Some of them are listed below.

Drivers

  • Presence of federal bodies for organizing awareness programs
  • Increasing awareness in developed countries
  • Technological advancements in healthcare
  • Increasing array of newborn diseases
  • More physicians advising newborn screening tests

Restraints

  • Lack of awareness in developing countries
  • Lack of trained professionals
  • Socio-economic barriers in developing countries

The global newborn screening market has been segmented based on technology, product, test type, and geography. The segmentation based on technology has been subdivided into tandem mass spectrometry, DNA-based assay, enzyme, and immunoassays, electrophoresis, hearing screening technology, and pulse oximetry technology. The segmentation based on product is sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, pulse oximetry, and reagents and assay kits. The segmentation based on test type has been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

Amongst technologies being used, tandem mass spectrometry is expected to have the highest growth rate during the forecast period. The dry blood spot test has the largest market share in the segment by test type.

Based on geography, the global newborn screening test market has been segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in the USA, Canada, and Mexico. The Europe segment has been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

Some of the key players in the market are:

  • AB Sciex LLC
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Covidien PLC
  • PerkinElmer Inc.
  • Trivitron Healthcare

What the Report Offers

  • Market definition for the global newborn screening market along with identification of key drivers and restraints for the market.
  • Market analysis for the newborn screening test market, with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the newborn screening test market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

  • 1.1. Study deliverables
  • 1.2. Market Definition
  • 1.3. Sizing Units
  • 1.4. Base Currency
  • 1.5. Review and Forecast period years
  • 1.6. General Study Assumptions

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Analysis Methodology
  • 2.3. Econometric Forecast Model
  • 2.4. Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry trends

  • 5.1. Current Market Scenario
  • 5.2. Newborn Screening test Applications
  • 5.3. Technology Overview
  • 5.4. New Developments
  • 5.5. Industry Value chain analysis
  • 5.6. Product Lifecycle analysis
  • 5.7. Product Benchmarking
  • 5.8. Investment Analysis
  • 5.9. Porter's Five Forces
    • 5.9.1. Bargaining Power of Suppliers
    • 5.9.2. Bargaining Power of Consumers
    • 5.9.3. Threat to new entrants
    • 5.9.4. Threat to substitute products and services
    • 5.9.5. Competitive Rivalry within the industry

6. Drivers, Restraints, Opportunities, and challenges Analysis

  • 6.1. Market Drivers
    • 6.1.1. Presence of federal bodies for organizing awareness programs
    • 6.1.2. Increasing awareness in Developed countries
    • 6.1.3. Technological Advancements
    • 6.1.4. Government support
    • 6.1.5. Increasing array of newborn diseases
  • 6.2. Market Restraints
    • 6.2.1. Lack of awareness in developing countries
    • 6.2.2. Lack of trained professional
    • 6.2.3. Socio- economic barriers in developing nations
      • 6.2.3.1. Market Opportunities
      • 6.2.3.2. Government Initiatives
      • 6.2.3.3. Market Challenges
  • 6.3. Lack of advanced healthcare facilities in developing nations
  • 6.4. Lack of awareness amongst a large population globally

7. Global Newborn Screening Market segmentation

  • 7.1. Introduction
  • 7.2. Segmentation by Technology
    • 7.2.1. Tandem Mass Spectrometry
    • 7.2.2. DNA based assay
    • 7.2.3. Enzymes and Immunoassays
    • 7.2.4. Electrophoresis
    • 7.2.5. Hearing Screen Technology
    • 7.2.6. Pulse Oximetry Technology
  • 7.3. Segmentation by Product
    • 7.3.1. Newborn disorder Screening Instruments
    • 7.3.2. Hearing screening devices, and Accessories
    • 7.3.3. Pulse Oximetry
    • 7.3.4. Reagents and assay kits
  • 7.4. Segmentation by test type
    • 7.4.1. Critical Congenital Heart Disease (CCHD) Test
    • 7.4.2. Hearing Screening Test
    • 7.4.3. Dry blood Spot Test

8. Market segmentation by Geography - North America

  • 8.1. North America
    • 8.1.1. Introduction
    • 8.1.2. United States
    • 8.1.3. Canada
    • 8.1.4. Mexico
  • 8.2. Europe
    • 8.2.1. Introduction
    • 8.2.2. Germany
    • 8.2.3. United Kingdom
    • 8.2.4. France
    • 8.2.5. Italy
    • 8.2.6. Spain
    • 8.2.7. Scandinavia
    • 8.2.8. BENELUX
    • 8.2.9. Rest of Europe
  • 8.3. Asia-Pacific (APAC)
    • 8.3.1. Introduction
    • 8.3.2. China
    • 8.3.3. Japan
    • 8.3.4. India
    • 8.3.5. Australia and New Zealand
    • 8.3.6. South Korea
    • 8.3.7. Rest of Asia-Pacific
  • 8.4. Middle East and North Africa
    • 8.4.1. Introduction
    • 8.4.2. GCC
    • 8.4.3. Egypt
    • 8.4.4. Rest of Middle East & Africa
  • 8.5. South America
    • 8.5.1. Introduction
    • 8.5.2. Brazil
    • 8.5.3. Argentina
    • 8.5.4. Rest of Latin America

9. Competitive Landscape

  • 9.1. Merger and acquisition analysis
  • 9.2. New Product Launches
  • 9.3. Agreements, Collaborations, and Partnerships

10. Key Vendor Analysis

  • 10.1. Agilent Technologies
  • 10.2. AB Sciex LLC
  • 10.3. Covidien PLC
  • 10.4. PerkinElmer Inc.
  • 10.5. Trivitron Healthcare
  • 10.6. Bio-Rad Laboratories
  • 10.7. Masimo Corporation
  • 10.8. Natus Medical
  • 10.9. Waters Corporation
  • 10.10. GE Healthcare

11. Analyst outlook for Investment opportunities

12. Future Outlook of the market

Back to Top